West Pharmaceutical (WST +9.8%) shares break out to an eight-month high after the company issues upside guidance for Q1. WST sees EPS of $0.83, excluding non-recurring items, vs. $0.65 consensus, on revenues of $316M vs. $308M consensus. FY 2012 EPS estimate is raised to $2.50-$2.67 vs. $2.47 consensus.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs